Momenta Pharmaceuticals to Present At Upcoming Conferences
Posted on: Wednesday, 5 November 2008, 18:00 CST
CAMBRIDGE, Mass., Nov. 5, 2008 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that management will present a company overview at two upcoming conferences.
* Craig Wheeler, Chief Executive Officer, will present at the 2008 Deutsche Bank Biotech Boston Confab in Boston at the Taj Boston Hotel on Tuesday, November 11th at 10:50 a.m. EST. * Rick Shea, Chief Financial Officer, will present at the Rodman and Renshaw 10th Annual Healthcare Conference in New York on Tuesday, November 11th at 12:25 p.m. EST at The New York Palace Hotel.
A live audio webcast of each presentation will be available on the "Investors" section of the Company's website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available through February 11, 2009.
About Momenta
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. Momenta was founded in 2001 based on technology initially developed at Massachusetts Institute of Technology and is headquartered in Cambridge, MA.
To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.
Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.
This news release was distributed by GlobeNewswire, www.globenewswire.com
CONTACT: Momenta Pharmaceuticals, Inc. Investor Relations Beverly Holley 617-395-5189
Source: PrimeNewswire
Related Articles
- Momenta Pharmaceuticals to Present at 9th Annual MASS Opportunities Investment Conference
- Hollis-Eden Pharmaceuticals Presents Positive Results With Novel Drug Candidate HE3235 in Model of Hormone Independent Prostate Cancer
- Momenta Pharmaceuticals Presents Preclinical Data for Novel Anticoagulant M118 At American College of Cardiology
- Momenta Pharmaceuticals to Present At the Cowen and Company 27th Annual Health Care Conference
- Hollis-Eden Pharmaceuticals Presents Additional Positive Data With Drug Candidate HE3286 in Model of Rheumatoid Arthritis
- Momenta Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 2006
- Momenta Pharmaceuticals Files Investigational New Drug Application for Novel Anticoagulant for Acute Coronary Syndromes
- Momenta Pharmaceuticals to Present at the Bear Stearns Biotech Boston Confab
- Momenta Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference
 |
 |
User Comments (0)
RSS Feeds